Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?
Background: The effectiveness of self-monitoring of blood glucose (SMBG) in type 2 diabetes mellitus (T2DM) patients is debated in the literature. We aimed at elucidating the association and patterns of complications between SMBG use and plasma glucose values. Methods: This cross-sectional study...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University Library System, University of Pittsburgh
2021-06-01
|
Series: | International Journal of Medical Students |
Subjects: | |
Online Access: | https://ijms.info/IJMS/article/view/786 |
_version_ | 1797718584014667776 |
---|---|
author | Andrew Thomas Mohan T. Shenoy K.T. Shenoy Nirmal George |
author_facet | Andrew Thomas Mohan T. Shenoy K.T. Shenoy Nirmal George |
author_sort | Andrew Thomas |
collection | DOAJ |
description |
Background: The effectiveness of self-monitoring of blood glucose (SMBG) in type 2 diabetes mellitus (T2DM) patients is debated in the literature. We aimed at elucidating the association and patterns of complications between SMBG use and plasma glucose values.
Methods: This cross-sectional study comprised 303 participants from outpatient departments with T2DM for over 12 months. We analyzed sociodemographic and clinical variables including: anthropometry, SMBG use, disease duration, treatment modality, complications, plasma glucose level, and glycated hemoglobin level (%).
Results: The mean duration of T2DM was 93 ± 76 months. Participants were grouped into SMBG users (n=115, 38%) and non-SMBG users (n=188, 62%). The mean fasting plasma glucose levels of SMBG and non-SMBG users were 140.7±42.7 (95% Confidence Interval [95%CI]: 132.72;148.67) mg/dl and 145.4±50 (95%CI: 138.12;152.67) mg/dl (p=0.03), respectively. The mean post-prandial plasma glucose levels of the SMBG and non-SMBG groups were 202 ± 63.42 (95%CI: 190.23;213.76) mg/dl and 209±84.54 (95%CI: 196.56;221.43) mg/dl (p=0.002), respectively. The mean difference in HbA1c among the groups were 8.14±1.69% (95%CI: 7.59;8.68) and 8.15±1.98% (95%CI: 7.27;9.02) (p=0.4), respectively. Hypoglycemia (n=50, 43.5%) was the most common complication. The prevalence of neuropathy (n=5, 4.3%, p=0.036) and cardiovascular disease (n=21, 18.3%, p=0.042) were significantly higher in the SMBG group.
Conclusion: Although plasma glucose values were significantly lower in the SMBG group, its clinical significance remains questionable. Furthermore, many participants in both groups had shortfalls in awareness, monitoring, and glycemic control. SMBG use needs to be evaluated in a cohort of patients with T2DM with adequate health awareness.
|
first_indexed | 2024-03-12T08:52:29Z |
format | Article |
id | doaj.art-06a4f81969c54c73b472c16d6e53a82c |
institution | Directory Open Access Journal |
issn | 2076-6327 |
language | English |
last_indexed | 2024-03-12T08:52:29Z |
publishDate | 2021-06-01 |
publisher | University Library System, University of Pittsburgh |
record_format | Article |
series | International Journal of Medical Students |
spelling | doaj.art-06a4f81969c54c73b472c16d6e53a82c2023-09-02T16:13:32ZengUniversity Library System, University of PittsburghInternational Journal of Medical Students2076-63272021-06-019210.5195/ijms.2021.786Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?Andrew Thomas0Mohan T. Shenoy1K.T. Shenoy2Nirmal George3Medical student, Sree Gokulam Medical College and Research Foundation, Trivandrum, IndiaMBBS, MD, DM, Consultant Endocrinologist, Department of Endocrinology, Sree Gokulam Medical College and Research Foundation, Trivandrum, IndiaMBBS, MD, DM, Professor and Head of department, Department of Gastroenterology, Sree Gokulam Medical College and Research Foundation, Trivandrum, IndiaMBBS, MD, Assistant Professor, Department of Pharmacology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India Background: The effectiveness of self-monitoring of blood glucose (SMBG) in type 2 diabetes mellitus (T2DM) patients is debated in the literature. We aimed at elucidating the association and patterns of complications between SMBG use and plasma glucose values. Methods: This cross-sectional study comprised 303 participants from outpatient departments with T2DM for over 12 months. We analyzed sociodemographic and clinical variables including: anthropometry, SMBG use, disease duration, treatment modality, complications, plasma glucose level, and glycated hemoglobin level (%). Results: The mean duration of T2DM was 93 ± 76 months. Participants were grouped into SMBG users (n=115, 38%) and non-SMBG users (n=188, 62%). The mean fasting plasma glucose levels of SMBG and non-SMBG users were 140.7±42.7 (95% Confidence Interval [95%CI]: 132.72;148.67) mg/dl and 145.4±50 (95%CI: 138.12;152.67) mg/dl (p=0.03), respectively. The mean post-prandial plasma glucose levels of the SMBG and non-SMBG groups were 202 ± 63.42 (95%CI: 190.23;213.76) mg/dl and 209±84.54 (95%CI: 196.56;221.43) mg/dl (p=0.002), respectively. The mean difference in HbA1c among the groups were 8.14±1.69% (95%CI: 7.59;8.68) and 8.15±1.98% (95%CI: 7.27;9.02) (p=0.4), respectively. Hypoglycemia (n=50, 43.5%) was the most common complication. The prevalence of neuropathy (n=5, 4.3%, p=0.036) and cardiovascular disease (n=21, 18.3%, p=0.042) were significantly higher in the SMBG group. Conclusion: Although plasma glucose values were significantly lower in the SMBG group, its clinical significance remains questionable. Furthermore, many participants in both groups had shortfalls in awareness, monitoring, and glycemic control. SMBG use needs to be evaluated in a cohort of patients with T2DM with adequate health awareness. https://ijms.info/IJMS/article/view/786Blood Glucose Self-MonitoringType 2 Diabetes MellitusGlycemic ControlBlood glucoseDiabetes Complications |
spellingShingle | Andrew Thomas Mohan T. Shenoy K.T. Shenoy Nirmal George Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful? International Journal of Medical Students Blood Glucose Self-Monitoring Type 2 Diabetes Mellitus Glycemic Control Blood glucose Diabetes Complications |
title | Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful? |
title_full | Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful? |
title_fullStr | Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful? |
title_full_unstemmed | Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful? |
title_short | Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful? |
title_sort | glucometers for patients with type 2 diabetes mellitus are they helpful |
topic | Blood Glucose Self-Monitoring Type 2 Diabetes Mellitus Glycemic Control Blood glucose Diabetes Complications |
url | https://ijms.info/IJMS/article/view/786 |
work_keys_str_mv | AT andrewthomas glucometersforpatientswithtype2diabetesmellitusaretheyhelpful AT mohantshenoy glucometersforpatientswithtype2diabetesmellitusaretheyhelpful AT ktshenoy glucometersforpatientswithtype2diabetesmellitusaretheyhelpful AT nirmalgeorge glucometersforpatientswithtype2diabetesmellitusaretheyhelpful |